India · Delayed Price · Currency is INR Emcure Pharmaceuticals Statistics
Total Valuation
NSE:EMCURE has a market cap or net worth of INR 343.99 billion. The enterprise value is 357.99 billion.
| Market Cap | 343.99B |
| Enterprise Value | 357.99B |
Important Dates
The last earnings date was Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:EMCURE has 189.59 million shares outstanding. The number of shares has increased by 1.33% in one year.
| Current Share Class | 189.59M |
| Shares Outstanding | 189.59M |
| Shares Change (YoY) | +1.33% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 70.40% |
| Owned by Institutions (%) | 9.29% |
| Float | 41.62M |
Valuation Ratios
The trailing PE ratio is 37.20 and the forward PE ratio is 29.83. NSE:EMCURE's PEG ratio is 1.61.
| PE Ratio | 37.20 |
| Forward PE | 29.83 |
| PS Ratio | 3.74 |
| PB Ratio | 6.91 |
| P/TBV Ratio | 8.94 |
| P/FCF Ratio | 59.01 |
| P/OCF Ratio | 36.46 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.02, with an EV/FCF ratio of 61.41.
| EV / Earnings | 38.73 |
| EV / Sales | 3.89 |
| EV / EBITDA | 20.02 |
| EV / EBIT | 26.06 |
| EV / FCF | 61.41 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.43 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 2.61 |
| Interest Coverage | 9.56 |
Financial Efficiency
Return on equity (ROE) is 19.57% and return on invested capital (ROIC) is 16.23%.
| Return on Equity (ROE) | 19.57% |
| Return on Assets (ROA) | 9.62% |
| Return on Invested Capital (ROIC) | 16.23% |
| Return on Capital Employed (ROCE) | 24.10% |
| Weighted Average Cost of Capital (WACC) | 4.25% |
| Revenue Per Employee | 13.67M |
| Profits Per Employee | 1.37M |
| Employee Count | 6,731 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 1.67 |
Taxes
In the past 12 months, NSE:EMCURE has paid 3.46 billion in taxes.
| Income Tax | 3.46B |
| Effective Tax Rate | 26.87% |
Stock Price Statistics
The stock price has increased by +43.46% in the last 52 weeks. The beta is -0.02, so NSE:EMCURE's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | +43.46% |
| 50-Day Moving Average | 1,745.24 |
| 200-Day Moving Average | 1,523.76 |
| Relative Strength Index (RSI) | 54.79 |
| Average Volume (20 Days) | 231,767 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:EMCURE had revenue of INR 92.04 billion and earned 9.24 billion in profits. Earnings per share was 48.77.
| Revenue | 92.04B |
| Gross Profit | 55.46B |
| Operating Income | 13.74B |
| Pretax Income | 12.87B |
| Net Income | 9.24B |
| EBITDA | 17.89B |
| EBIT | 13.74B |
| Earnings Per Share (EPS) | 48.77 |
Balance Sheet
The company has 1.48 billion in cash and 15.21 billion in debt, with a net cash position of -13.74 billion or -72.46 per share.
| Cash & Cash Equivalents | 1.48B |
| Total Debt | 15.21B |
| Net Cash | -13.74B |
| Net Cash Per Share | -72.46 |
| Equity (Book Value) | 49.77B |
| Book Value Per Share | 261.12 |
| Working Capital | 17.00B |
Cash Flow
In the last 12 months, operating cash flow was 9.44 billion and capital expenditures -3.61 billion, giving a free cash flow of 5.83 billion.
| Operating Cash Flow | 9.44B |
| Capital Expenditures | -3.61B |
| Depreciation & Amortization | 4.15B |
| Net Borrowing | 4.88B |
| Free Cash Flow | 5.83B |
| FCF Per Share | 30.75 |
Margins
Gross margin is 60.26%, with operating and profit margins of 14.92% and 10.04%.
| Gross Margin | 60.26% |
| Operating Margin | 14.92% |
| Pretax Margin | 13.99% |
| Profit Margin | 10.04% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 14.92% |
| FCF Margin | 6.33% |
Dividends & Yields
This stock pays an annual dividend of 3.60, which amounts to a dividend yield of 0.20%.
| Dividend Per Share | 3.60 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.15% |
| Buyback Yield | -1.33% |
| Shareholder Yield | -1.13% |
| Earnings Yield | 2.69% |
| FCF Yield | 1.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:EMCURE is 1,913.50, which is 6.01% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,913.50 |
| Price Target Difference | 6.01% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 11.94% |
| EPS Growth Forecast (3Y) | 19.60% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |